Rigel Pharmaceuticals | RIGL - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Agenus USD 58.98M 12.1M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Celldex Therapeutics USD 14.68M 4.32M 2026-06
Daiichi Sankyo JPY 539.05B 57.81B 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Heron Therapeutics USD 11.64M 2.67M 2026-06
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Ligand Pharmaceuticals USD 9.4M 27.7M 2026-06
MacroGenics USD 3.44M 845K 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pfizer USD 4.58B 75M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Veracyte USD 8.02M 1.12M 2026-06